Skip to main content

Jaume Alijotas Reig

Institutions of which they are part

Head of group
Systemic Diseases
Vall Hebron Institut de Recerca

Jaume Alijotas Reig

Institutions of which they are part

Head of group
Systemic Diseases
Vall Hebron Institut de Recerca

Research lines

Proinflammatory cytokines TNF and IL-6 in cellular senescence. A HUVEC aging model.

Cells that are chronically exposed to inflammatory signals are more prone to aging than those which are not exposed to such signals. Human vascular endothelial cell (HUVEC) primary cultures activated with TNF-alpha probably increase the expression of ICAM and VCAM, synthesize ROS, and express senescence markers. It is not known what the principal intracellular pathway is (although it is thought that STAT may play a role) and it is unknown if one or more proinflammatory cytokines are needed to activate NF-KB. We are trying to find out the role that IFN-alpha and/or IL-6 and IL-1B may have on the aging inflammatory phenomena and we aim at detecting the intracellular signal pathways (STAT). We are also working on the characterization of the genes involved in these abnormal biologic responses.

IP: Jaume Alijotas Reig

Immunological basis and new therapeutic options in severe preeclampsia.

Three to five percent of pregnancies are complicated by preeclampsia (PE). PE is a multisystemic-related endothelial dysfunction disorder characterized by hypertension, proteinuria and renal injury. Despite considerable research, its etiology and pathophysiology still remains unclear. Different theories involving many pathways including thrombophilia, immunologic changes, circulating angiogenic /antiangiogenic factors and increased oxidative stress have been related to its pathogenesis. The role played by antiphospholipid antibodies (aPL) is a matter of discussion in PE.  Biological evidence of endothelial dysfunction related to PE/FGR has been shown by modified plasma markers including fibronectin, von Willebrand factor and ICAM-1 in a similar manner to that which occurs in aPL-related obstetric complications. We are searching now the role played by different aPL and cofactor antibodies, as well as its relationship with angiogenic /antiangiogenic factors and microparticle number in severe PE.

IP: Jaume Alijotas Reig, Elisa Llurba Olivé, Anna Suy Franch

Projects

Heparina de Bajo Peso Molecular (HBPM) para la prevención de complicaciones derivadas de la insuficiencia placentaria en las pacientes de riesgo sin trombofilia: estudio multicéntrico randomizado

IP: -
Collaborators: Jaume Alijotas Reig, Inés Zulema Calero Fernández, Elisa Llurba Olivé, Josep Perapoch López
Funding agency: Ministerio Sanidad
Funding: 80000
Reference: EC10-205
Duration: 01/01/2011 - 31/12/2016

Envejecimiento endotelial y sus efectos pleiotrópicos sobre procesos inflamatorios, de la respuesta inmune y angiogénesis

IP: Francesc Miro Mur
Collaborators: Jaume Alijotas Reig, Simon Schwartz Navarro
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 36000
Reference: FMMA/05/2008
Duration: 24/09/2008 - 23/09/2011

CIBER: Bioingenieria, biomateriales y nanomedicina

IP: -
Collaborators: Manuel López Cano, Jaume Alijotas Reig, Francesc Miro Mur, Eloy Espín Basany
Funding agency: CIBER Bioing., Biomateriales y Nanomedicina , BBN
Funding: 480000
Reference: CB06/01/0012
Duration: 01/01/2007 - 31/12/2010

Related news

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

Related professionals

Olga Luengo Sanchez

Olga Luengo Sanchez

Systemic Diseases
Read more
Anna Salo Rovira

Anna Salo Rovira

Research technician
Childhood Cancer and Blood Disorders
Read more
Estefania De la Torre Villaescusa

Estefania De la Torre Villaescusa

Head of unit
Teaching Unit
Internal Strategy Directorate
Read more
José Manuel Vidal Taboada

José Manuel Vidal Taboada

Main researcher
Peripheral Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.